28. March 2024 | Corporate News

Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months

  • Agreement with the EIB provides for a deferral of all capital repayments for 18 months, while interest rates remain unchanged
  • Real estate lenders also agreed to suspend repayments for 18 months
  • Marinomed plans to achieve significant milestones in 2024, including further deals for the Marinosolv platform

The full press release is available as download here: 

Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
(56 KB)